. 2015 Oct 21;2015:475630. doi: 10.1155/2015/475630

Table 2.

PDQ-8, VAS-pain, and CGI-S scores at baseline and after 3 months of months of nightly treatment with rotigotine transdermal patch in the efficacy population (n = 74).

Assessment scale	Mean ± SD score
Assessment scale	Baseline	EOT
PDQ-8	23.8 ± 18.6	18.2 ± 17.7^a
VAS-pain	3.2 ± 2.5	2.3 ± 2.4^a
CGI-S	3.7 ± 0.6	3.5 ± 0.7

^a p < 0.001 versus baseline.

CGI-S, Clinical Global Impression of Severity; EOT, end of treatment; PDQ-8, short-form Parkinson's Disease Questionnaire; SD, standard deviation; VAS, visual analogue scale.